BR112013014184A2 - compostos de triazina [1,2,4] triazolo [4,3-b][1,2,4], método de preparo e seu uso - Google Patents
compostos de triazina [1,2,4] triazolo [4,3-b][1,2,4], método de preparo e seu usoInfo
- Publication number
- BR112013014184A2 BR112013014184A2 BR112013014184-0A BR112013014184A BR112013014184A2 BR 112013014184 A2 BR112013014184 A2 BR 112013014184A2 BR 112013014184 A BR112013014184 A BR 112013014184A BR 112013014184 A2 BR112013014184 A2 BR 112013014184A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- compound
- triazolo
- triazine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105792210A CN102532141A (zh) | 2010-12-08 | 2010-12-08 | [1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途 |
CN201010579221.0 | 2010-12-08 | ||
PCT/CN2011/002052 WO2012075683A1 (zh) | 2010-12-08 | 2011-12-08 | [1,2,4]三唑并[4,3-b][1,2,4]三嗪类化合物、其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013014184A2 true BR112013014184A2 (pt) | 2018-08-14 |
Family
ID=46206563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013014184-0A BR112013014184A2 (pt) | 2010-12-08 | 2011-12-08 | compostos de triazina [1,2,4] triazolo [4,3-b][1,2,4], método de preparo e seu uso |
Country Status (11)
Country | Link |
---|---|
US (1) | US20130324542A1 (pt) |
EP (1) | EP2650293A1 (pt) |
JP (1) | JP2013544853A (pt) |
KR (1) | KR20130094849A (pt) |
CN (1) | CN102532141A (pt) |
AU (1) | AU2011339933A1 (pt) |
BR (1) | BR112013014184A2 (pt) |
CA (1) | CA2820389A1 (pt) |
MX (1) | MX2013006443A (pt) |
RU (1) | RU2013129969A (pt) |
WO (1) | WO2012075683A1 (pt) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201007286D0 (en) | 2010-04-30 | 2010-06-16 | Astex Therapeutics Ltd | New compounds |
GB201020179D0 (en) | 2010-11-29 | 2011-01-12 | Astex Therapeutics Ltd | New compounds |
GB201118675D0 (en) | 2011-10-28 | 2011-12-14 | Astex Therapeutics Ltd | New compounds |
GB201118654D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118656D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201118652D0 (en) | 2011-10-28 | 2011-12-07 | Astex Therapeutics Ltd | New compounds |
GB201209613D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
GB201209609D0 (en) | 2012-05-30 | 2012-07-11 | Astex Therapeutics Ltd | New compounds |
CN103497177B (zh) * | 2012-09-29 | 2017-03-22 | 天津滨江药物研发有限公司 | 作为c‑Met抑制剂的氨基芳香杂环类化合物及其制备方法 |
US20150284380A1 (en) | 2012-10-31 | 2015-10-08 | Bayer Cropscience Ag | Novel heterocyclic compounds as pest control agents |
GB201307577D0 (en) | 2013-04-26 | 2013-06-12 | Astex Therapeutics Ltd | New compounds |
CN103319432B (zh) * | 2013-06-28 | 2015-02-18 | 江苏倍达医药科技有限公司 | 一种合成伊拉地平药物中间体4-甲酰基苯并呋咱的方法 |
WO2015144808A1 (en) | 2014-03-26 | 2015-10-01 | Astex Therapeutics Ltd | Combinations of an fgfr inhibitor and an igf1r inhibitor |
JO3512B1 (ar) | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
SI3122358T1 (sl) * | 2014-03-26 | 2021-04-30 | Astex Therapeutics Ltd. | Kombinacije FGFR- in CMET-inhibitorjev za zdravljenje raka |
JOP20200201A1 (ar) | 2015-02-10 | 2017-06-16 | Astex Therapeutics Ltd | تركيبات صيدلانية تشتمل على n-(3.5- ثنائي ميثوكسي فينيل)-n'-(1-ميثيل إيثيل)-n-[3-(ميثيل-1h-بيرازول-4-يل) كينوكسالين-6-يل]إيثان-1.2-ثنائي الأمين |
US10478494B2 (en) | 2015-04-03 | 2019-11-19 | Astex Therapeutics Ltd | FGFR/PD-1 combination therapy for the treatment of cancer |
BR112018005637B1 (pt) | 2015-09-23 | 2023-11-28 | Janssen Pharmaceutica Nv | Compostos derivados de quinoxalina, quinolina e quinazolinona,composições farmacêuticas que os compreende, e uso dos referidos compostos |
ES2904513T3 (es) | 2015-09-23 | 2022-04-05 | Janssen Pharmaceutica Nv | 1,4-Benzodiazepinas biheteroarilo sustituidas y usos de las mismas para el tratamiento del cáncer |
CN108276415B (zh) * | 2018-02-08 | 2019-07-05 | 台州职业技术学院 | 一种烷氧化三唑并四嗪类化合物及其制备方法和应用 |
SG11202103131UA (en) * | 2018-09-28 | 2021-04-29 | Acucela Inc | Inhibitors of vap-1 |
BR112021018168B1 (pt) | 2019-03-21 | 2023-11-28 | Onxeo | Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer |
KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
CN112341373B (zh) * | 2020-11-30 | 2022-04-08 | 山东嘉成医药科技有限公司 | 一种酞丁安的制备方法 |
KR20230073040A (ko) | 2021-11-18 | 2023-05-25 | (주)웨컨 | 회전식 미생물 접촉장치 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005005378A2 (en) | 2003-07-02 | 2005-01-20 | Sugen, Inc. | Indolinone hydrazides as c-met inhibitors |
US7122548B2 (en) * | 2003-07-02 | 2006-10-17 | Sugen, Inc. | Triazolotriazine compounds and uses thereof |
US7250417B2 (en) | 2003-07-02 | 2007-07-31 | Sugen Inc. | Arylmethyl triazolo- and imidazopyrazines as c-Met inhibitors |
US7037909B2 (en) | 2003-07-02 | 2006-05-02 | Sugen, Inc. | Tetracyclic compounds as c-Met inhibitors |
ME02736B (me) * | 2005-12-21 | 2017-10-20 | Janssen Pharmaceutica Nv | Triazolopiridazini kao modulatori tirozin kinaze |
NL2000613C2 (nl) | 2006-05-11 | 2007-11-20 | Pfizer Prod Inc | Triazoolpyrazinederivaten. |
US8217177B2 (en) * | 2006-07-14 | 2012-07-10 | Amgen Inc. | Fused heterocyclic derivatives and methods of use |
WO2008051808A2 (en) | 2006-10-23 | 2008-05-02 | Sgx Pharmaceuticals, Inc. | Bicyclic triazoles as protein kinase modulators |
-
2010
- 2010-12-08 CN CN2010105792210A patent/CN102532141A/zh active Pending
-
2011
- 2011-12-08 WO PCT/CN2011/002052 patent/WO2012075683A1/zh active Application Filing
- 2011-12-08 RU RU2013129969/04A patent/RU2013129969A/ru unknown
- 2011-12-08 CA CA2820389A patent/CA2820389A1/en not_active Abandoned
- 2011-12-08 KR KR1020137017673A patent/KR20130094849A/ko not_active Application Discontinuation
- 2011-12-08 JP JP2013542336A patent/JP2013544853A/ja not_active Withdrawn
- 2011-12-08 US US13/992,048 patent/US20130324542A1/en not_active Abandoned
- 2011-12-08 BR BR112013014184-0A patent/BR112013014184A2/pt not_active IP Right Cessation
- 2011-12-08 MX MX2013006443A patent/MX2013006443A/es not_active Application Discontinuation
- 2011-12-08 AU AU2011339933A patent/AU2011339933A1/en not_active Abandoned
- 2011-12-08 EP EP11846471.8A patent/EP2650293A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US20130324542A1 (en) | 2013-12-05 |
AU2011339933A1 (en) | 2013-07-11 |
JP2013544853A (ja) | 2013-12-19 |
WO2012075683A1 (zh) | 2012-06-14 |
KR20130094849A (ko) | 2013-08-26 |
MX2013006443A (es) | 2013-10-17 |
EP2650293A8 (en) | 2013-12-25 |
CA2820389A1 (en) | 2012-06-14 |
EP2650293A1 (en) | 2013-10-16 |
CN102532141A (zh) | 2012-07-04 |
RU2013129969A (ru) | 2015-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013014184A2 (pt) | compostos de triazina [1,2,4] triazolo [4,3-b][1,2,4], método de preparo e seu uso | |
EA201000552A1 (ru) | Производные пирроло[2,3-d]пиримидина в качестве ингибиторов протеинкиназы в | |
EA201001017A1 (ru) | 3h-[1,2,3]триазоло[4,5-d]пиримидиновые соединения, их применение в качестве ингибиторов киназы mtor и киназы pi3 и их синтезы | |
WO2012047017A3 (ko) | 2,3-디히드로-이소인돌-1-온 유도체 및 이를 포함하는 조성물 | |
CR10419A (es) | Derivados de Pirazolo [3,4-D]-Pirimidina útiles para tratar trastornos respiratorios | |
EA201070167A1 (ru) | Замещенные производные индазола, активные как ингибиторы киназы | |
EA201000615A1 (ru) | Производные имидазо[1,2-а]пиридина, применимые в качестве ингибиторов апк (активиноподобной киназы) | |
EA201000090A1 (ru) | Тризамещенные производные пиримидина для лечения пролиферативных заболеваний | |
EA201000091A1 (ru) | ПРОИЗВОДНЫЕ МОРФОЛИНОПИРИМИДИНА, ИСПОЛЬЗУЕМЫЕ ПРИ ЗАБОЛЕВАНИЯХ, СВЯЗАННЫХ С mTOR КИНАЗОЙ И/ИЛИ PI3K | |
MY180666A (en) | Substituted pyrazolo [3,4-b] pyridines as medicaments | |
GEP20156417B (en) | Pyrrolo [2,3-d] pyrimidine derivatives as inhibitors of tropomyosin-related kinases | |
MX2009008953A (es) | Compuestos como inhibidores de angiogenesis. | |
WO2009091374A3 (en) | Fused heterocyclic derivatives and methods of use as c-met inhibitors | |
MX2009009843A (es) | Compuestos espiro sustituidos como inhibidores de la angiogenesis. | |
WO2010066684A3 (en) | Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease | |
EA201290237A1 (ru) | Киназные ингибиторы | |
WO2009143211A3 (en) | Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same | |
EA201000092A1 (ru) | Тризамещенные пиримидиновые производные для лечения пролиферативных заболеваний | |
WO2009155527A3 (en) | Phosphatidylinositol 3 kinase inhibitors | |
WO2010021918A8 (en) | Compounds as kinase inhibitors | |
EA201070929A1 (ru) | ФУРО- И ТИЕНО[3,2-c]ПИРИДИНЫ | |
WO2013004995A8 (en) | Pyrimidinone compounds and their use | |
AU2013270326B2 (en) | Pyrrolo[2,1-f][1,2,4]triazine compound, and preparation method and application thereof | |
MX2014003194A (es) | 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina. | |
WO2007009723A3 (en) | Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2486 DE 28-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |